KCM
INSM icon

Kingdon Capital Management’s Insmed INSM Stock Holding History

Kingdon Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-47,800
Closed -$3.2M – 95
2024
Q2 		$3.2M Sell
47,800
-152,200
-76% -$5.9M 0.34% 71
2024
Q1 		$5.43M Buy
+200,000
New +$5.6M 0.59% 69

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kingdon Capital Management's INSM Position: Q2 2025 in Review

Kingdon Capital Management sold out of Insmed (INSM) in Q2 2025, closing a stake of 215,000 shares — an estimated $16.4M sold.

Kingdon Capital Management first reported a position in INSM in Q3 2014 and held it in 7 quarters. The position peaked at $41.9M in Q2 2024. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Kingdon Capital Management reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Kingdon Capital Management sold 215,000 Insmed shares in Q2 2025, an estimated $16.4M.
  • Kingdon Capital Management first reported a position in Insmed in Q3 2014 and held it in 7 quarters.
  • Kingdon Capital Management's Insmed position peaked at $41.9M in Q2 2024.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Kingdon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.